• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetic interaction of single doses of quinine and carbamazepine, phenobarbitone and phenytoin in healthy volunteers.

作者信息

Amabeoku G J, Chikuni O, Akino C, Mutetwa S

机构信息

Department of Clinical Pharmacology, Medical School, University of Zimbabwe, Harare.

出版信息

East Afr Med J. 1993 Feb;70(2):90-3.

PMID:8513749
Abstract

Effects of single doses of quinine on plasma and urine concentrations of carbamazepine, phenobarbitone and phenytoin were studied in healthy volunteers. Quinine (600mg, p.o.) markedly augmented the peak plasma concentrations and area under the curve (AUC [0-24]) values of carbamazepine (200mg,p.o.) and phenobarbitone (120mg,p.o.) but did not affect those of phenytoin (200mg,p.o.). Mean urinary recoveries of carbamazepine, phenobarbitone and phenytoin over 24 hours also profoundly increased with concomitant administration of quinine. These results indicate possible interaction between quinine and carbamazepine or phenobarbitone.

摘要

相似文献

1
Pharmacokinetic interaction of single doses of quinine and carbamazepine, phenobarbitone and phenytoin in healthy volunteers.
East Afr Med J. 1993 Feb;70(2):90-3.
2
Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.缬草、苯妥英、苯巴比妥和卡马西平与姜黄素在大鼠癫痫实验模型中的药代动力学和药效学相互作用。
Pharmacol Biochem Behav. 2011 Sep;99(3):399-407. doi: 10.1016/j.pbb.2011.05.011. Epub 2011 May 30.
3
Interaction of carbamazepine and phenobarbital in rabbits.卡马西平与苯巴比妥在兔体内的相互作用。
Biomed Chromatogr. 2000 Aug;14(5):344-8. doi: 10.1002/1099-0801(200008)14:5<344::AID-BMC994>3.0.CO;2-E.
4
Antiepileptic TDM pattern at a tertiary care hospital in India.印度一家三级护理医院的抗癫痫药物治疗药物监测模式。
Nepal Med Coll J. 2006 Jun;8(2):107-10.
5
N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model.N-(苯胺甲基)-对异丙氧基苯基琥珀酰亚胺在小鼠最大电休克诱导癫痫模型中增强苯巴比妥和丙戊酸的抗惊厥作用。
Neurosci Res. 2009 Jul;64(3):267-72. doi: 10.1016/j.neures.2009.03.010. Epub 2009 Mar 31.
6
Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.卡马西平与苯妥英钠的相互作用:联合使用卡马西平导致血浆苯妥英钠浓度升高。
Ther Drug Monit. 1985;7(1):51-3.
7
Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.在最大电休克小鼠模型中对瑞马西胺与传统抗癫痫药物相互作用的等效线图分析。
Epilepsy Behav. 2007 Aug;11(1):6-12. doi: 10.1016/j.yebeh.2007.04.018. Epub 2007 Jun 29.
8
Factors influencing plasma carbamazepine concentrations.影响血浆卡马西平浓度的因素。
Clin Exp Neurol. 1977;14:184-93.
9
Aminophylline alters pharmacokinetics of carbamazepine but not that of sodium valproate--a single dose pharmacokinetic study in human volunteers.氨茶碱改变卡马西平的药代动力学,但不改变丙戊酸钠的药代动力学——一项在人类志愿者中的单剂量药代动力学研究。
Indian J Physiol Pharmacol. 1995 Apr;39(2):122-6.
10
Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects.米氮平与苯妥英钠的联合使用:一项在健康男性受试者中的药物相互作用研究。
Eur J Clin Pharmacol. 2002 Sep;58(6):423-9. doi: 10.1007/s00228-002-0498-6. Epub 2002 Aug 14.

引用本文的文献

1
Pharmacokinetic interactions of antimalarial agents.抗疟药的药代动力学相互作用。
Clin Pharmacokinet. 2001;40(5):343-73. doi: 10.2165/00003088-200140050-00003.
2
Pharmacokinetics of carbamazepine derived from a new tablet formulation.一种新片剂剂型的卡马西平的药代动力学
Eur J Drug Metab Pharmacokinet. 1995 Oct-Dec;20(4):297-300. doi: 10.1007/BF03190248.
3
Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.奎宁、氯喹和阿莫地喹的药代动力学。临床意义。
Clin Pharmacokinet. 1996 Apr;30(4):263-99. doi: 10.2165/00003088-199630040-00002.